Search for: "H. LUNDBECK A/S" Results 1 - 20 of 55
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Object of the extension of patent term regime In both cases, the Full Federal Court discussed the rationale for the current extension of term regime, by reference to the comments made by the High Court in Alphapharm Pty Limited v H Lundbeck A/S [2014] HCA 42; (2014) 254 CLR 247. [read post]
14 Mar 2022, 10:13 pm by Jackie O'Brien (AU)
Background H Lundbeck A/S (Lundbeck Denmark) owned a patent relating to the pharmaceutical substance escitalopram. [read post]
14 Mar 2022, 10:13 pm by Jackie O'Brien (AU)
Background H Lundbeck A/S (Lundbeck Denmark) owned a patent relating to the pharmaceutical substance escitalopram. [read post]
Background H Lundbeck A/S (Lundbeck Denmark) owned a patent relating to the pharmaceutical substance escitalopram. [read post]
7 Jan 2020, 7:26 am
In addition to the often cited passage of Kitchin J in Generics v H Lundbeck ([2007] EWHC 1040) on the factors for obviousness, Lord Hodge added &ldq [read post]
19 Sep 2018, 11:28 am by msatta
”[4] The Supreme Court once reversed him for reading an “unwritten exception” into a law he didn’t like, because “[h]owever sensible” his dislike of it might have been, a “court’s task is to apply the text [of a statute], not to improve upon it. [read post]
5 Sep 2018, 4:00 am by Alice Woolley
At one point Hochschild describes a defamation suit brought against an African-American missionary, the Rev William H Sheppard, who had worked to expose the grotesque cruelty occurring in the Congo, and the advocacy of Sheppard’s Belgian lawyer Vandervelde. [read post]
8 Aug 2018, 4:00 am by Administrator
Lundbeck A/S and Lundbeck Canada Inc. [read post]
22 Sep 2016, 7:10 am
Lundbeck A/S [2007] EWHC 1040 (Pat) (reported by the IPKat here):"The question of obviousness must be considered on the facts of each case. [read post]
28 May 2016, 7:13 pm by Mark Summerfield
Furthermore, it has been held that ‘everything that is within the scope of a claim must be useful, otherwise the claim will fail for inutility’ (H Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70 at [81]).One aspect of the utility requirement that has perhaps been less consistently addressed is whether, if a patent applicant makes multiple promises for an invention, it is necessary that all of those promises be met by every claim. [read post]
9 Jun 2015, 1:06 pm
“More than one-fifth of all health-related disability is caused by mental ill health, studies suggest,” wrote Allan H. [read post]
7 Nov 2014, 10:49 pm by Mark Summerfield
  Hot on the heels of the High Court’s ruling, a single judge of the Federal Court of Australia has handed the latest round in this part of the dispute to Lundbeck, dismissing an appeal from the Commissioner’s decision to allow the extension: Alphapharm Pty Ltd v H Lundbeck A/S [2014] FCA 1185.A great deal of money is at stake in all of this. [read post]